Conference Coverage (ASCO)

Risks Associated with Chemotherapy-Based Transfusion Requirements are Quantified

Published in Cancer Weekly, June 1st, 1998

In the never-ending saga of chemotherapy induced complications, a new study provides hope that platinum-based chemotherapy-induced anemia in ovarian cancer patients can be prevented before it occurs.

David Heddens, representing colleagues from the Arizona Cancer Center, the University of Texas Medical Branch, and the Southwest Oncology Group, Texas, presented study results that quantified the risks associated with chemotherapy-induced anemia requiring blood transfusion at the 34th Annual Meeting of the American Society of Clinical Oncology, held May 16-19, 1998, in Los Angeles, California (abstract "Factors Associated with Platinum-Induced Anemia in Ovarian Cancer...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1998-06-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry